Skip to main content

Table 1 Baseline patient demographical and clinical characteristics

From: Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome

Patient characteristics

No. (%)

Mean ± SEM

Gender

  

  Female

41 (61.2)

 

  Male

26 (38.8)

 

Age (y)

 

77.48 ± 0.91

Age group

  

  <70 y

12 (17.9)

 

  70-80 y

27 (40.3)

 

  >80 y

28 (41.8)

 

Using AREDS supplements

41 (61.2)

 

Smoking

  

  Yes

7 (10.4)

 

  No

37 (55.2)

 

  Past

12 (17.9)

 

  Missing

11 (16.4)

 

Hypertension

  

  Yes

47 (70.1)

 

  No

19 (28.4)

 

  Missing

1 (1.5)

 

Diabetes mellitus

  

  Yes

17 (25.4)

 

  No

48 (71.6)

 

  Missing

2 (3)

 

Ischemic heart disease

  

  Yes

18 (26.9)

 

  No

47 (70.1)

 

  Missing

2 (3)

 
  1. SEM = standard error of the mean; y = years.